Compare · EVGN vs NTR
EVGN vs NTR
Side-by-side comparison of Evogene Ltd (EVGN) and Nutrien Ltd. (NTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EVGN and NTR operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- NTR is the larger of the two at $33.53B, about 5307.0x EVGN ($6.3M).
- Over the past year, EVGN is down 69.0% and NTR is up 24.1% - NTR leads by 93.1 points.
- EVGN has been more active in the news (11 items in the past 4 weeks vs 4 for NTR).
- NTR has more recent analyst coverage (25 ratings vs 4 for EVGN).
- Company
- Evogene Ltd
- Nutrien Ltd.
- Price
- $0.39-1.33%
- $71.28+2.41%
- Market cap
- $6.3M
- $33.53B
- 1M return
- -22.62%
- -9.71%
- 1Y return
- -69.04%
- +24.10%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2004
- News (4w)
- 11
- 4
- Recent ratings
- 4
- 25
Evogene Ltd
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Nutrien Ltd.
Nutrien Ltd. provides crop inputs, services, and solutions. The company offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Latest EVGN
- SEC Form 6-K filed by Evogene Ltd
- Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
- SEC Form 4 filed by Director Recanati Leon
- SEC Form 4 filed by Director Nimrodi Nir
- SEC Form 4 filed by Director Percy Adrian John
- SEC Form 4 filed by Director Falk Dan Michael
- SEC Form 6-K filed by Evogene Ltd
- Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
- SEC Form EFFECT filed by Evogene Ltd
- SEC Form 6-K filed by Evogene Ltd
Latest NTR
- Nutrien Announces Release Dates for Third Quarter 2026 Results and Conference Call
- SEC Form 6-K filed by Nutrien Ltd.
- Nutrien Provides Update on Trinidad Nitrogen Operations
- Nutrien to Host Investor Day on November 30
- KeyBanc Capital Markets initiated coverage on Nutrien
- Nutrien downgraded by National Bank Financial with a new price target
- SEC Form SD filed by Nutrien Ltd.
- SEC Form 6-K filed by Nutrien Ltd.
- SEC Form 6-K filed by Nutrien Ltd.
- Nutrien Declares Quarterly Dividend of US$0.55 per Share